Search research articles
Contact Us
Filters
Showing results (381-390 of 416) with videos related to
Page
of 42
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
March 4, 2014
RAS mutations and cetuximab in locally advanced rectal cancer: results of the EXPERT-C trial
F Sclafani, D Gonzalez, D Cunningham, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 26, 1998
Bolus injection (2-4 min) versus short-term (10-20 min) infusion of 5-fluorouracil in patients with advanced colorectal cancer: a prospective randomised trial. Nordic Gastrointestinal Tumour Adjuvant Therapy Group
B Glimelius, A Jakobsen, W Graf, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 11, 2009
A window of opportunity phase II study of enzastaurin in chemonaive patients with asymptomatic metastatic colorectal cancer
B Glimelius, M Lahn, S Gawande, et al.
ESMO Open
|
October 22, 2023
Corrigendum to "Authors' reply-Does the RAPIDO trial suggest a benefit of post-operative chemotherapy after preoperative chemoradiation in rectal cancer? No, it does not": [ESMO Open 8 (2023) 101645]
W H Zwart, E A Dijkstra, H Putter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 29, 2022
Authors' reply-A sensitivity analysis of the RAPIDO clinical trial
E A Dijkstra, W H Zwart, H Putter, et al.
ESMO Open
|
September 15, 2023
Authors' reply-Does the RAPIDO trial suggest a benefit of post-operative chemotherapy after preoperative chemoradiation in rectal cancer? No, it does not
W H Zwart, E A Dijkstra, H Putter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 3, 2019
Total circulating cell-free DNA as a prognostic biomarker in metastatic colorectal cancer before first-line oxaliplatin-based chemotherapy
J Hamfjord, T K Guren, O Dajani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 12, 2002
Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients
C H Köhne, D Cunningham, F Di Costanzo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 25, 2016
PAN-EX: a pooled analysis of two trials of neoadjuvant chemotherapy followed by chemoradiotherapy in MRI-defined, locally advanced rectal cancer
F Sclafani, G Brown, D Cunningham, et al.
The New England Journal of Medicine
|
September 8, 2001
Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer
E Kapiteijn, C A Marijnen, I D Nagtegaal, et al.
Page
of 42
Search research articles
Search
Showing results (381-390 of 416) with videos related to
Sort By:
Page
of 42
European Journal of Cancer (Oxford, England : 1990)
|
March 4, 2014
RAS mutations and cetuximab in locally advanced rectal cancer: results of the EXPERT-C trial
F Sclafani, D Gonzalez, D Cunningham, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 26, 1998
Bolus injection (2-4 min) versus short-term (10-20 min) infusion of 5-fluorouracil in patients with advanced colorectal cancer: a prospective randomised trial. Nordic Gastrointestinal Tumour Adjuvant Therapy Group
B Glimelius, A Jakobsen, W Graf, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 11, 2009
A window of opportunity phase II study of enzastaurin in chemonaive patients with asymptomatic metastatic colorectal cancer
B Glimelius, M Lahn, S Gawande, et al.
ESMO Open
|
October 22, 2023
Corrigendum to "Authors' reply-Does the RAPIDO trial suggest a benefit of post-operative chemotherapy after preoperative chemoradiation in rectal cancer? No, it does not": [ESMO Open 8 (2023) 101645]
W H Zwart, E A Dijkstra, H Putter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 29, 2022
Authors' reply-A sensitivity analysis of the RAPIDO clinical trial
E A Dijkstra, W H Zwart, H Putter, et al.
ESMO Open
|
September 15, 2023
Authors' reply-Does the RAPIDO trial suggest a benefit of post-operative chemotherapy after preoperative chemoradiation in rectal cancer? No, it does not
W H Zwart, E A Dijkstra, H Putter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 3, 2019
Total circulating cell-free DNA as a prognostic biomarker in metastatic colorectal cancer before first-line oxaliplatin-based chemotherapy
J Hamfjord, T K Guren, O Dajani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 12, 2002
Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients
C H Köhne, D Cunningham, F Di Costanzo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 25, 2016
PAN-EX: a pooled analysis of two trials of neoadjuvant chemotherapy followed by chemoradiotherapy in MRI-defined, locally advanced rectal cancer
F Sclafani, G Brown, D Cunningham, et al.
The New England Journal of Medicine
|
September 8, 2001
Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer
E Kapiteijn, C A Marijnen, I D Nagtegaal, et al.
Page
of 42